Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6784266

CC(=O)Oc1ccc(C[C@H](N)C(=O)OCc2ccccc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.50
LAP3 P28838 1/20 0.50
PTPN1 P18031 1/20 0.48
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
SLC15A1 P46059 1/20 0.44
ALPI P09923 1/20 0.43
PKM P14618 1/20 0.43
PTGS1 P23219 1/20 0.43
XIAP P98170 1/20 0.43
SLC7A5 Q01650 1/20 0.43
ITGB3 P05106 5/20 0.43
ITGA2B P08514 5/20 0.43
GAA P10253 1/20 0.42
GRB2 P62993 1/20 0.42
ELANE P08246 1/20 0.41
OPRK1 P41145 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24942191 0.94 LTA4H (0.55) LTA4HLAP3ALDH1A1POLBKMT2A
Trifluoroacetic Acid SCHEMBL28278079 0.88 ALPI (0.54) LTA4HLAP3PTPN1ALDH1A1KMT2A
SCHEMBL31177328 0.84 PTPN1 (0.54) LTA4HLAP3PTPN1ALDH1A1SLC15A1
SCHEMBL5222410 0.83 LTA4H (0.55) LTA4HLAP3ALDH1A1SLC15A1ALPI
Trifluoroacetic Acid SCHEMBL28836301 0.83 LTA4H (0.43) LTA4HLAP3PTPN1ALDH1A1SLC15A1
Trifluoroacetic Acid SCHEMBL30098504 0.83 LTA4H (0.43) LTA4HLAP3PTPN1ALDH1A1SLC15A1
Trifluoroacetic Acid SCHEMBL30098486 0.83 LTA4H (0.43) LTA4HLAP3PTPN1ALDH1A1SLC15A1
Trifluoroacetic Acid SCHEMBL28836548 0.83 LTA4H (0.43) LTA4HLAP3PTPN1ALDH1A1SLC15A1
SCHEMBL15634364 0.82 LTA4H (0.56) LTA4HLAP3ALDH1A1SLC15A1ALPI
SCHEMBL8907360 0.82 LTA4H (0.56) LTA4HLAP3ALDH1A1SLC15A1ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006104-A1 Neutrophil inhibitors to reduce inflammatory response THE PROCTER & GAMBLE COMPANY 2004-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006104-A1 Neutrophil inhibitors to reduce inflammatory response MPO, SERPINB1, NCF1 LTA4H 125/4885LAP3 2958/4885PTPN1 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.